Stevens Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-516	Closed	-$215K	–	128
2022 Q3	$215K	Buy	+516	New	+$257K	0.14%	123
2022 Q2	–	Sell	-835	Closed	-$470K	–	136
2022 Q1	$470K	Buy	835 +497	+147%	+$300K	0.1%	172
2021 Q4	$255K	Buy	+338	New	+$253K	0.06%	217
2019 Q4	–	Sell	-1,744	Closed	-$580K	–	606
2019 Q3	$580K	Sell	1,744 -14,341	-89%	-$4.68M	0.05%	326
2019 Q2	$5.03M	Buy	16,085 +2,859	+22%	+$856K	0.22%	134
2019 Q1	$4.04M	Buy	13,226 +9,595	+264%	+$2.59M	0.17%	163
2018 Q4	$843K	Sell	3,631 -13,262	-79%	-$3.56M	0.04%	410
2018 Q3	$5.29M	Buy	16,893 +6,505	+63%	+$2.02M	0.19%	150
2018 Q2	$3M	Buy	10,388 +2,733	+36%	+$755K	0.11%	222
2018 Q1	$1.91M	Buy	7,655 +1,795	+31%	+$457K	0.07%	299
2017 Q4	$1.4M	Buy	+5,860	New	+$1.42M	0.05%	364
2017 Q3	–	Sell	-3,272	Closed	-$740K	–	852
2017 Q2	$740K	Sell	3,272 -11,259	-77%	-$2.45M	0.03%	494
2017 Q1	$2.9M	Buy	14,531 +7,602	+110%	+$1.46M	0.11%	252
2016 Q4	$1.26M	Buy	6,929 +4,345	+168%	+$741K	0.05%	391
2016 Q3	$423K	Buy	+2,584	New	+$392K	0.02%	603
2016 Q1	–	Sell	-14,379	Closed	-$1.99M	–	895
2015 Q4	$1.99M	Buy	14,379 +8,803	+158%	+$1.22M	0.08%	284
2015 Q3	$749K	Buy	5,576 +3,172	+132%	+$457K	0.03%	421
2015 Q2	$362K	Sell	2,404 -4,490	-65%	-$642K	0.01%	695
2015 Q1	$932K	Buy	6,894 +1,092	+19%	+$135K	0.03%	429
2014 Q4	$699K	Buy	5,802 +1,050	+22%	+$121K	0.02%	499
2014 Q3	$539K	Buy	+4,752	New	+$563K	0.02%	572
2013 Q4	–	Sell	-9,582	Closed	-$1.13M	–	1014
2013 Q3	$1.13M	Buy	9,582 +3,030	+46%	+$357K	0.03%	460
2013 Q2	$735K	Buy	+6,552	New	+$769K	0.02%	499